This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...
The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added ...
Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.
AZoLifeSciences on MSN30m
Synthetic Biology and the Next Generation of Microbiota-Based TherapiesInnovative synthetic biology techniques are revolutionizing microbiota-based therapies, enhancing microbial functions for ...
Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research ...
AZoLifeSciences on MSN7d
Integrating CRISPR and biomaterials engineering: Paving the way for safer gene therapiesLehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...
The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...
CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...
Ongoing launch of CASGEVY® continues to gain momentum--2025 is poised to be a catalyst-rich year with key updates across several ...
Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of CRISPR Therapeutics ...
Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback